The immunocompromised traveller. An Advisory Committee Statement (ACS).
D003967:Diarrhea / Q000517:prevention & control; D015658:HIV Infections / Q000150:complications; D006373:Helminthiasis / Q000517:prevention & control; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects; D009181:Mycoses / Q000517:prevention & control; D009369:Neoplasms / Q000150:complications; D012749:Sexually Transmitted Diseases / Q000517:prevention & control; D013156:Splenectomy / Q000009:adverse effects; D014180:Transplantation / Q000009:adverse effects; D014195:Travel; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014612:Vaccines / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D014612:Vaccines